Compounds > hexamethonium
Page last updated: 2024-10-28

hexamethonium and Coronary Disease

hexamethonium has been researched along with Coronary Disease in 3 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PACIFICO, A1
Cinca, J1
Rodríguez-Sinovas, A1
Anivarro, I1
Moure, C1
Tresànchez, M1
Soler-Soler, J1
Ohyanagi, M1
Matsumori, Y1
Iwasaki, T1

Other Studies

3 other studies available for hexamethonium and Coronary Disease

ArticleYear
[Limitations and possibilities of hexamethonium in cardiovascular pathology].
    La Riforma medica, 1956, Apr-07, Volume: 70, Issue:14

    Topics: Cardiovascular Agents; Cardiovascular Diseases; Coronary Disease; Hexamethonium; Humans; Muscle Rela

1956
Neurally mediated depressor hemodynamic response induced by intracoronary catheter balloon inflation in pigs.
    Cardiovascular research, 2000, Volume: 46, Issue:1

    Topics: Analysis of Variance; Angioplasty, Balloon, Coronary; Animals; Atropine; Autonomic Nervous System; C

2000
Beta-adrenergic receptors in ischemic and nonischemic canine myocardium: relation to ventricular fibrillation and effects of pretreatment with propranolol and hexamethonium.
    Journal of cardiovascular pharmacology, 1988, Volume: 11, Issue:1

    Topics: Animals; Coronary Disease; Coronary Vessels; Cyclic AMP; Dogs; Heart; Hexamethonium; Hexamethonium C

1988